Definium Therapeutics Us, Inc.
Clinical trials sponsored by Definium Therapeutics Us, Inc., explained in plain language.
-
Could a tiny dose of LSD help adults with ADHD?
Disease control CompletedThis study tested whether repeated low doses of LSD (called MM120) can safely help adults with ADHD. Fifty-three adults took either the drug or a placebo, and researchers measured changes in ADHD symptoms using a standard rating scale. The goal was to see if this approach could b…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
LSD shows promise for anxiety in new clinical trial
Symptom relief CompletedThis Phase 2 study tested four different doses of MM120 (a form of LSD) against a placebo in 198 people with generalized anxiety disorder. The goal was to see which dose best reduces anxiety symptoms over 4 to 8 weeks. Participants took a single dose and were monitored for safety…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC